Fontan Considerations II (put Fontan I and II together in sequence)

The Australia/New Zealand Fontan Registry
Presented by David Celermajer, MBBS, MSc, PhD, DSc, FAHA, FRACP, FAA
The University of Sydney
David Celermajer is the Scandrett Professor of Cardiology at The University of Sydney and Director of Echocardiography in the Cardiology Department at Royal Prince Alfred Hospital, as well as Staff Cardiologist at the Children’s Hospital in Westmead. He has been Group Leader of the Clinical Research Group of the the Heart Research Institute since 1994, and in 2003 was appointed as Clinical Director of the Heart Research Institute. He sits on the National Heart Foundation of Australia’s Cardiovascular Health Advisory Committee and is currently also a Board Member of the                                        Menzies School of Health Research in the Northern Territory.


Today’s Best Management Strategies for PLE
Presented by Anitha John,MD, PhD
Children’s National Health System

 Anitha John, MD, PhD, is the Director of the Washington Adult Congenital Heart (WACH) Program at Children’s National Medical Center in Washington, D.C. She completed a dual MD-PhD program in Medicine and Molecular Pathobiology and proceeded to train in internal medicine and pediatrics at Brown University School of Medicine before moving on to do a Pediatric Cardiology Fellowship at The Children’s Hospital of Philadelphia. She became one of a handful of physicians with subspecialty training in Adult Congenital Heart Disease when she completed an Adult Congenital Cardiology Fellowship at the Mayo Clinic. She is also among the first cohort of cardiologists to be Board-Certified in the newly-recognized subspecialty of Adult Congenital Cardiology. Dr. John is committed to research, leading several studies in congenital heart disease and participating in several multicenter studies. These studies have resulted in multiple publications and grant funding. Her research, focused on clinical outcomes in congenital cardiology, is dedicated to discovering the best tools for maintaining lifelong health and improving quality of life for the next generation of CHD patients. She is deeply committed to her patients, organizing a regional collaborative of adult congenital heart programs for the improvement of clinical care of patients in addition to fostering research collaborations


Lymphatics as a Potential Therapeutic Target
Presented by Yoav Dori, MD, PhD 
Director of Pediatric Lymphatic Imaging and Interventions and Lymphatic Research
The Children’s Hospital of Philadelphia


Dr. Dori is a pediatric interventional cardiologist and lymphatic interventionalist with training in cardiac MRI and a Ph.D. in Chemical Engineering.  Together with Dr. Itkin he started the Center for Lymphatic Imaging and Interventions and is the Director of Pediatric Lymphatic Imaging and Interventions and Lymphatic Research.   His main clinical and research interest are in lymphatic flow disorders and the interface between the lymphatic and             cardiovascular system.


Emerging Mechanical Support for the Failing Fontan
Presented by Thomas K. Jones, MD
University of Washington School of Medicine
Seattle Children’s Hospital

jones-thomasA Professor of Pediatrics and Adjunct Professor of Medicine at the University of Washington School of Medicine and the Director of the Cardiac Catheterization Laboratories at Seattle Children’s Hospital.  Dr. Jones is a graduate of the Jefferson Medical College in Philadelphia.  After completing his pediatrics residency at the University of Washington and his pediatric cardiology fellowship training at the University of Colorado and the Denver Children’s Hospital, Dr. Jones returned to Seattle where he spent the first 8 years of his career in private practice.  In 1991 Dr. Jones helped create the Children’s Heart Center at the Seattle Children’s Hospital.  In the same year he joined the academic faculty of the University of Washington and became the first Director of the Cardiac Catheterization Laboratories at the Seattle Children’s Hospital.

Dr. Jones’ lifelong work has focused on congenital and structural interventional cardiac catheterization in children and adults.  He has worked to pioneer several less invasive techniques to correct congenital heart conditions.  He has authored over 100 manuscripts, book chapters, and editorials and has participated as an investigator in over 30 multi-center clinical trials in the U.S.  Dr. Jones collaborates with emerging technology companies to develop and test new products designed to treat congenital and structural heart conditions. His research interests are currently focused on percutaneous heart valve implantation.  He continues to serve on national committees and task forces promoting clinical guidelines and practice standards for patients with congenital heart disease. He is collaborates with the FDA on novel approval pathways to improve patient access to more effective cardiovascular devices needed to treat the uncommon conditions that congenital cardiologists face every day.


Transplant Considerations–When, Where, and What?
Presented by Stephanie Fuller, MD, MS
The Children’s Hospital of Philadelphia

fuller-stephanieAn attending surgeon in the Division of Cardiothoracic Surgery at The Children’s Hospital of Philadelphia. She is also an Associate Professor at the Perelman School of Medicine at the University of Pennsylvania. She is board certified in general surgery, thoracic surgery and congenital cardiothoracic surgery.  In addition to her pediatric patients, Dr. Fuller also operates on adult patients at Penn Medicine’s Hospital of the University of Pennsylvania and Pennsylvania Hospital (both in Philadelphia). She is the Surgical Director of the Philadelphia Adult Congenital Heart Center, a joint                                         program of The Children’s Hospital of Philadelphia and Penn                                                 Medicine.
Dr. Fuller lectures nationally and internationally and has published numerous peer-reviewed articles and has authored and co-authored numerous chapters for cardiothoracic surgery textbooks. She has leadership appointments at the Society of Thoracic Surgeons, American College of Cardiology and American Heart Association.

Dr. Fuller earned her medical degree from Eastern Virginia Medical School, Norfolk, VA, and then underwent nine years of training before she was appointed a surgeon at The Children’s Hospital of Philadelphia, including a residency in general surgery at Albert Einstein Medical Center, Philadelphia, and residencies in cardiothoracic surgery at George Washington University, Washington, DC, and Thomas Jefferson University Hospital, Philadelphia. She completed her training with a fellowship in congenital cardiothoracic surgery at The Children’s Hospital of Philadelphia.

Her research interests include adult congenital heart disease, neurodevelopmental outcomes and other quality of life outcomes after heart surgery; genetic factors in heart defects; and quality of life into adolescence and young adulthood in patients with pulmonary atresia with intact ventricular septum.

(No Ratings Yet)